Cancer Institute– A national cancer institute
designated cancer center

Peter Greenberg

Back to Profile

Publication Details

  • Phase II Study of Lenalidomide in Transfusion-Dependent, Low and Intermediate-1-Risk Myelodysplastic Syndromes with Normal and Abnormal Karyotypes Other than Deletion 5q.

    Raza A, Reeves JE, Feldman EJ, Dewald GW, Bennett JM, Deeg HJ, Dreisbach L, Schiffer CA, Stone RM, Greenberg PL, et al. Blood. 2008: 111 86-93

Stanford Medicine Resources:

Footer Links: